The recommendation for the vaccine in children (the vaccine is for use only in children) comes following advice from the WHO Strategic Advisory Group of Experts on Immunization (SAGE) and the Malaria Policy Advisory Group (MPAG) and was endorsed by the WHO Director-General following its regular biannual meeting held on 25-29 September. The R21 or Matrix-M vaccine, is only the second malaria vaccine in the world to be recommended by WHO and has been developed by scientists at the Oxford University and will be produced by Pune-based vaccine maker Serum Institute of India (SII). New Delhi: The World Health Organisation…